According to Torrent Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.74029. At the end of 2023 the company had a P/S ratio of 7.51.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.51 | 35.34% |
2022 | 5.55 | -17.32% |
2021 | 6.71 | 9.54% |
2020 | 6.13 | 53.37% |
2019 | 4.00 | -1.11% |
2018 | 4.04 | -7.61% |
2017 | 4.37 | 15.36% |
2016 | 3.79 | -1.92% |
2015 | 3.87 | -2.55% |
2014 | 3.97 | 86.33% |
2013 | 2.13 | 3.22% |
2012 | 2.06 |